REFERENCES
1. Cahill N, Sonneveldt E, Stover J, Weinberger M, Williamson J, Wei C, et al. Modern contraceptive use, unmet need, and demand satisfied among women of reproductive age who are married or in a union in the focus countries of the Family Planning 2020 initiative: a systematic analysis using the Family Planning Estimation Tool. Lancet. 2018;391(10123):870-82.
2. Committee Opinion No. 670: Immediate Postpartum Long-Acting Reversible Contraception. Obstet Gynecol. 2016;128(2) e32-e7.
3. Birgisson NE, Zhao Q, Secura GM, Madden T, Peipert JF. Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in Review. Journal of Women’s Health. 2105;24(5):349-53.
4. Morse J, Freedman L, Speidel JJ, Thompson KM, Stratton L, Harper CC. Postabortion contraception: qualitative interviews on counseling and provision of long-acting reversible contraceptive methods. Perspect Sex Reprod Health. 2012;44(2):100-6.
5. Masilela S. Improvement in abortion and contraception led by data-driven decisions in gauteng province, South Africa. International Journal of Gynecology and Obstetrics. 2015;2015(131):e65.
6. Harper C, Thompson K, Waxman NJ, Speidel J. Provision of long-acting reversible contraception at US abortion facilities and barriers to immediate postabortion insertion. Contraception. 2009;80(2):197-8.
7. Chersich MF, Wabiri N, Risher K, Shisana O, Celentano D, Rehle T, et al. Contraception coverage and methods used among women in South Africa: a national household survey. S Afr Med J. 2017;107(4):307-14.
8. Baldwin MK, Edelman AB. The effect of long-acting reversible contraception on rapid repeat pregnancy in adolescents: a review. J Adolesc Health. 2013;52(4 Suppl):S47-53.
9. Korjamo R, Mentula M, Heikinheimo O. Immediate versus delayed initiation of the levonorgestrel-releasing intrauterine system following medical termination of pregnancy - 1 year continuation rates: a randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology. 2017;124(13):1957-64.
10. Hohmann HL, Reeves MF, Chen BA, Perriera LK, Hayes JL, Creinin MD. Immediate versus delayed insertion of the levonorgestrel-releasing intrauterine device following dilation and evacuation: a randomized controlled trial. Contraception. 2012;85(3):240-5.
11. Okusanya BO, Oduwole O, Effa EE. Immediate postabortal insertion of intrauterine devices. Cochrane Database Syst Rev. 2014(7):CD001777.
12. Cooper M, Cameron ST. Successful implementation of immediate postpartum intrauterine contraception services in Edinburgh and framework for wider dissemination. Int J Gynaecol Obstet. 2018;143:56-61.
13. Jatlaoui TC, Whiteman MK, Jeng G, Tepper NK, Berry-Bibee E, Jamieson DJ, et al. Intrauterine Device Expulsion After Postpartum Placement: A Systematic Review and Meta-analysis. Obstetrics & Gynecology. 2018;132(4):895-905.
14. Lopez LM, Bernholc A, Hubacher D, Stuart G, Van Vliet HA. Immediate postpartum insertion of intrauterine device for contraception. Cochrane Database Syst Rev. 2015;6(CD003036).
15. Korjamo R, Mentula M, Heikinheimo O. Expulsions and adverse events following immediate and later insertion of a levonorgestrel-releasing intrauterine system after medical termination of late first- and second-trimester pregnancy: a randomised controlled trial. BJOG : an international journal of obstetrics and gynaecology. 2017;124(13):1965-72.
16. Korjamo R, Mentula M, Heikinheimo O. Fast-track vs. delayed insertion of the levonorgestrel-releasing intrauterine system after early medical abortion - a randomized trial. Contraception. 2017;96(5):344-51.
17. Cremer M, Bullard KA, Mosley RM, Weiselberg C, Molaei M, Lerner V, et al. Immediate vs. delayed post-abortal copper T 380A IUD insertion in cases over 12 weeks of gestation. Contraception. 2011;83(6):522-7.
18. Bednarek PH, Creinin MD, Reeves MF, Cwiak C, Espey E, Jensen JT, et al. Immediate versus delayed IUD insertion after uterine aspiration. N Engl J Med. 2011;364(23):2208-17.
19. Hognert H, Kopp Kallner H, Cameron S, Nyrelli C, Jawad I, Heller R, et al. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion—a randomized controlled equivalence trial. Human reproduction (Oxford). 2016;31(11):2484-90.
20. Appareddy S, Pryor J, Bailey B. Inter-pregnancy interval and adverse outcomes: Evidence for an additional risk in health disparate populations. J Matern Fetal Neonatal Med. 2017;30(21):2640-4.